Read + Share
Battat R. Authors' Reply to "Immunogenicity of Tumor Necrosis Factor Antagonists and Effect
of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in
Inflammatory Bowel Disease". Inflamm Bowel Dis 2022;28:e61.
PMID: 35512143
|
 |
|
